Riskpilot← Back to searchSign inGet full accessBrainlink AB
ABActiveOrg 5593707259Medicinaregatan 8 AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20221-4 employees
Revenue 2024
SEK 3,4M
+89% vs 2023
EBITDA margin
5.3%
+201% vs 2023
Equity ratio
32.1%
Financial strength
Net profit 2024
SEK 166K
+192% vs 2023
| Revenue | SEK 3,4M | +89% |
| EBITDA | SEK 181K | +201% |
| Net profit | SEK 166K | +192% |
| Total assets | SEK 2,7M | +31% |
| Equity | SEK 862K | +24% |
| Employees | — | — |
Legal name
Brainlink AB
Org number
5593707259
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
15 mars 2022
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Farahmand, Dan Farbod i förening med Sjöstedt, Dwight Sven Pierre Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är bolaget ska utveckla, framställa och sälja medicintekniska produkter för vården och därmed förenlig verksamhet.
Address
Medicinaregatan 8 A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 967 | 1 800 | 3 411 |
| Staff expenses | −62 | −715 | −1 434 |
| EBITDA | 1 072 | −179 | 181 |
| Depreciation & amort. | — | — | — |
| EBIT | 1 072 | −179 | 181 |
| Net financials | −0 | −0 | −7 |
| Profit before tax | 1 072 | −179 | 174 |
| Tax | −221 | — | −8 |
| Net profit | 851 | −179 | 166 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 1 423 | 2 050 | 2 689 |
| Equity | 876 | 697 | 862 |
| Long-term debt | 140 | 0 | — |
| Short-term debt | 407 | 1 354 | 1 827 |
| Total debt | 547 | 1 354 | 1 827 |
EBITDA margin
5.3%
This company
15.8%
Market median
-66% vs market
20222024
Equity ratio
32.1%
This company
38.2%
Market median
+16% vs market
20222024
Return on equity
19.2%
This company
18.4%
Market median
+4% vs market
20222024
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20222024
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
20222024
Debt / equity
2.12×
This company
0.62×
Market median
-242% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-03-15 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DF Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Brainlink AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Farbod Farahmand | Chief Executive Officer | 0 companies |
| Tony Patrik Tolf | Board of Directors | 0 companies |
| Charlotta Sofia Vedholm | Board of Directors | 0 companies |
| Ida Johanna Kristina Farahmand | Deputy Board Member | 0 companies |
| Dwight Sven Pierre Sjöstedt | Chairman | 0 companies |
| Hans David Christopher Nävås | Board of Directors | 0 companies |